Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.3 USD | -0.30% | +1.60% | +7.95% |
Apr. 25 | Cigna to offer Humira rivals with $0 copay at specialty pharmacy | RE |
Apr. 25 | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.